PZPatrick Zardo

Patrick Zardo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Patrick Zardo has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Non-intubated uniportal video-assisted minor and major pulmonary resections: a single-center European experience in 163 selected patients

    by Hayan Merhej, Alaa Selman, Daniel Benjamin Jaeger, Jan Karsten, Alina Meininger, Dietmar Boethig, Akylbek Saipbaev, Mihail Magdei, Tomoyuki Nakagiri, Norman Zinne, et al.

    Background: Non-intubated video-assisted thoracoscopic surgery (niVATS) avoids endotracheal intubation and one-lung mechanical ventilation. Whether this translates into clinically meaningful benefits compared with intubated video-assisted thoracoscopic surgery (VATS) requires comparative studies. Evidence from European centers, particularly for major pulmonary resections, remains limited. We evaluated technical feasibility and perioperative outcomes in a selected European niVATS cohort. Methods: This retrospective single-center observational study included consecutive patients selected to undergo niVATS between May 2018 and February 2025. The primary endpoint was intraoperative conversion to intubated anesthesia. Secondary endpoints included postoperative complications, chest tube duration, length of stay, reoperation, and 30-day mortality. Results: A total of 163 patients were included. Median age was 67 years and median body mass index (BMI) was 24 kg/m2. Anatomical lung resections were performed in 77 patients (47.2%), including 50 lobectomies and 27 segmentectomies. Conversion to intubated anesthesia occurred in 6 patients (3.7%). Prolonged air leak was observed in 21 patients (12.9%), pneumonia in 5 (3.1%), and reoperation in 6 (3.7%). Thirty-day mortality was 1.2%. Median chest tube duration and hospital stay were 3 and 5 days, respectively. Conversion was more frequently observed among patients undergoing lobectomy and among those with a higher BMI. Conclusions: niVATS is feasible in selected patients across a broad spectrum of thoracic procedures in a high-volume European center. Lobectomy and increasing BMI are associated with a higher likelihood of conversion and should be considered during patient selection and perioperative planning. These descriptive findings do not establish comparative safety or clinical benefit versus intubated VATS; prospective comparative studies are required.

  • Open Access

    Endothelial Responses to ICS/LABA Combinations Are Determined Primarily by the Corticosteroid Component

    by Bassam Redwan, Christian Biancosino, Amir Mehdizadeh-Shrifi, Felix Nikolaus Lennartz, Stefan Fischer, Karsten Wiebe, Marion Schael, Patrick Zardo, Sabina Janciauskiene, Heiko Golpon

    The pulmonary microvasculature plays an essential role in maintaining alveolar integrity, but the direct effects of inhaled corticosteroids (ICS) on pulmonary endothelial cell function remain poorly understood. We investigated the effects of budesonide, formoterol, and their combination on endothelial network formation, apoptosis, migration, proliferation, and efferocytosis using human pulmonary microvascular endothelial cells (HPMEC-ST1.6R), A549 alveolar epithelial cells, and phagocytic cell models. Budesonide, alone or combined with formoterol, altered endothelial network formation on Matrigel by reducing total tubule length and the number of junctions while increasing tubule thickness, indicating reduced branching complexity. Budesonide also decreased epithelial secretion of the pro-angiogenic mediators VEGF, IL-8, and MCP-1. An independent set of experiments showed that fluticasone propionate similarly reduced VEGF, IL-8, MCP-1, TNF-α, and IL-6, supporting a class effect of corticosteroids on the epithelial secretome. Despite reducing angiogenic responses, budesonide protected endothelial cells from apoptosis, reduced caspase-3/7 activity, accelerated wound closure without affecting proliferation, preserved endothelial spheroid integrity, and enhanced efferocytosis. Formoterol alone had minimal effects and did not consistently enhance budesonide responses. Together, these in vitro findings suggest that, in the cell models studied, pulmonary endothelial responses to the ICS/LABA combinations tested are determined predominantly by the corticosteroid component, which suppresses pro-angiogenic mediator secretion while preserving endothelial survival and repair. As an exploratory cell-based study, these observations are hypothesis-generating and require confirmation in primary cells and in vivo models before clinical inferences can be drawn.

  • Open Access

    Pressurized intrathoracic aerosol chemotherapy (PITAC) for malignant pleural mesothelioma—ex vivo evaluation of optimal treatment conditions and comparison with hyperthermic intrathoracic chemotherapy (HITOC)

    by Katharina Flöthmann, Norman Zinne, Peter Braubach, Alina Meininger, Imke Becker, Nicole Ernst, Arjang Ruhparwar, Hayan Merhej, Patrick Zardo

    Background: Malignant pleural mesothelioma (MPM) is a rare but aggressive disease with poor prognosis and limited treatment options. Pressurized intrathoracic aerosol chemotherapy (PITAC) has emerged as a novel approach for intrathoracic drug delivery. The aim of this study was to investigate cisplatin penetration characteristics and to evaluate procedural parameters influencing drug penetration, including temperature, drug concentration and pleural barrier function, in an ex vivo model. In addition, PITAC was compared with hyperthermic intrathoracic chemotherapy (HITOC), a treatment modality applied in selected specialized centers as part of multimodal treatment concepts for MPM. Methods: We investigated the penetration depth and intensity of aerosolized cisplatin generated using a high-pressure nebulizer in an ex vivo setting. Potential influencing factors, including temperature, cisplatin concentration and barrier function of the pleura, were gradually modified, as we sought to evaluate optimal procedural conditions. Finally, PITAC was compared with a previously standardized HITOC approach. Results: A temperature of 42 ℃, a cisplatin concentration of 1 mg/mL, and prior removal of the pleura, improved the penetration depth and intensity of the chemotherapeutic agent. Under clinically relevant experimental conditions, aerosolized cisplatin application demonstrated greater tissue penetration compared to HITOC. Conclusions: Our preclinical data suggest that PITAC may be a viable alternative to HITOC and warrants further clinical investigation.


  • Praktische Tipps und Tricks beim Thoraxtrauma

    by Akylbek Saipbaev, Tobias Goecke, Hayan Merhej, Tomoyuki Nakagiri, Alaa Selman, Patrick Zardo

    Thoraxtraumata sind noch immer mit erheblicher Morbidität und Mortalität assoziiert. Aus rein pragmatischer Sicht hat sich in den vergangenen Jahren eine Klassifizierung in 4 Gruppen bewährt, die unterschiedlicher Expertise und Infrastruktur zur optimalen Versorgung bedürfen. Der Großteil aller Patienten lässt sich jedoch noch immer suffizient mit der Anlage einer Thoraxdrainage therapieren. Article published online: 03 June 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

  • Uniportal Video-Assisted Anatomical Lung Volume Reduction Surgery in Severe Emphysema

    by Hayan Merhej, Akylbek Saipbaev, Tomoyuki Nakagiri, Alaa Selman, Heiko Golpon, Tobias Goecke, Patrick Zardo

    Lung volume reduction surgery (LVRS) is an important treatment option for patients with advanced emphysema and is typically performed in a non-anatomical fashion. This study reports the outcome of anatomical LVRS by means of uniportal video-assisted thoracoscopic surgery (VATS).We retrospectively evaluated patients who underwent anatomical LVRS between June 2017 and September 2023 at our institution. Patient characteristics, including demographic data, lung function, as well as morbidity and mortality, were extracted from hospital records.A total of 44 patients (17 males, 38.6%) underwent anatomical LVRS at our institution during the observation period. The preoperative forced expiratory volume per second (FEV1) and FEV1% were 35.4 ± 20.0% and 45.7 ± 18.2%, respectively. Lobectomy was performed in 37 patients (84.1%), while segmentectomy was performed in 10 patients (22.7%, duplicated). Postoperative FEV1 and FEV1% significantly improved compared to preoperative values at the initial follow-up (11.8 ± 6.9 months after the operation): 38.3 ± 19.5%, p < 0.002 and 49.4 ± 18.4%, p < 0.01, respectively. Unfortunately, two patients (4.5%) died within 30 days postoperation. A further follow-up lung function test was performed in 25 patients (56.8%) at 33.1 ± 13.8 months after the operation, showing that FEV1 and FEV1% remained similar to the preoperative values (33.9 ± 20.7%, p = 0.10 and 45.3 ± 18.1%, p = 0.06, respectively).Anatomical lung resection via uniportal VATS is an effective procedure for LVRS in patients with severe emphysema and is associated with acceptable morbidity and mortality.


  • Minimalinvasive Lungenchirurgie unter Spontanatmung (niVATS)

    by Patrick Zardo, Henning Starke

    Die minimalinvasive Lungenchirurgie unter Spontanatmung hat in den vergangenen Jahren an Bedeutung gewonnen und sich auch hierzulande für die Durchführung von „Minorprozeduren“ an vielen Zentren etabliert. „Majorprozeduren“ in dieser Technik sind derzeit eher Schwerpunktkliniken vorbehalten, zumal die diesbezügliche Datenlage noch unübersichtlich ist. Dieser Beitrag gibt einen Überblick über die historische Entwicklung des Verfahrens, soll kritisch Möglichkeiten und Limitationen beschreiben und Hilfestellung beim Aufbau eines entsprechenden Programms leisten. Non-intubated minimally invasive lung surgery garnered renewed interest during the past decade and many centers across the country successfully implemented the technique for minor procedures like pleurodesis or wedge resection. Anatomical lung resection under spontaneous breathing still is considered as challenging, and as existing data to support it is conflicting and confusing, the approach remains limited to few dedicated outfits. We seek to present the historical perspective, critically report potential advantages and limitations of the technique and hand out a guideline that might prove to be helpful in building up a dedicated program. Article published online: 13 August 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Long-Term Outcome of Chest Wall and Diaphragm Repair with Biological Materials

    by Hayan Merhej, Mohammed Ali, Tomoyuki Nakagiri, Norman Zinne, Alaa Selman, Heiko Golpon, Tobias Goecke, Patrick Zardo

    Introduction Chest wall and/or diaphragm reconstruction aims to preserve, restore, or improve respiratory function; conserve anatomical cavities; and upkeep postural and upper extremity support. This can be achieved by utilizing a wide range of different grafts made of synthetic, biological, autologous, or bioartificial materials. We aim to review our experience with decellularized bovine pericardium as graft in the past decade. Patients and Methods We conducted a retrospective analysis of patients who underwent surgical chest wall and/or diaphragm repair with decellularized bovine pericardium between January 1, 2012 and January 13, 2022 at our institution. All records were screened for patient characteristics, intra-/postoperative complications, chest tube and analgesic therapy duration, length of hospital stay, presence or absence of redo procedures, as well as morbidity and 30-day mortality. We then looked for correlations between implanted graft size and postoperative complications and gathered further follow-up information at least 2 months after surgery. Results A total of 71 patients either underwent isolated chest wall (n = 51), diaphragm (n = 12), or pericardial (n = 4) resection and reconstruction or a combination thereof. No mortality was recorded within the first 30 days. Major morbidity occurred in 12 patients, comprising secondary respiratory failure requiring bronchoscopy and invasive ventilation in 8 patients and secondary infections and delayed wound healing requiring patch removal in 4 patients. There was no correlation between the extensiveness of the procedure and extubation timing (chi-squared test, p = 0.44) or onset of respiratory failure (p = 0.27). Conclusion A previously demonstrated general viability of biological materials for various reconstructive procedures appears to be supported by our long-term results.

  • Surgical management of large tracheoesophageal fistula in infants after button battery ingestion

    by Murat Avsar, Tobias Goecke, Oliver Keil, Harald Koeditz, Nicolaus Schwerk, Joachim F Kuebler, Alexander Horke, Gregor Warnecke, Axel Haverich, Benno Ure, et al.

    OBJECTIVES: In recent years, an increase in severe and even fatal outcomes related to oesophageal or airway button battery (BB) ingestion by infants and small children has been reported. Extensive tissue necrosis caused by lodged BB can lead to major complications, including tracheoesophageal fistula (TEF). In these instances, best treatment remains controversial. While small defects may warrant a conservative approach, surgery often remains inevitable in highly complex cases with large TEF. We present a series of small children that underwent successful surgical management by a multidisciplinary team in our institution.METHODS: This is a retrospective analysis of n = 4 patients <18 months undergoing TEF repair from 2018 to 2021.RESULTS: Surgical repair under extracorporeal membrane oxygenation (ECMO) support was feasible in n = 4 patients by reconstructing the trachea with decellularized aortic homografts that were buttressed with pedicled latissimus dorsi muscle flaps. While direct oesophageal repair was feasible in 1 patient, 3 required esophagogastrostomy and secondary repair. The procedure was completed successfully in all 4 children with no mortality and acceptable morbidity.CONCLUSIONS: Tracheo-oesophageal repair after BB ingestion remains challenging and is associated with major morbidity. Bioprosthetic materials in conjunction with the interposition of vascularized tissue flaps between trachea and oesophagus appear to be a valid approach to manage severe cases.


  • Open Access

    Do we still need thoracic epidural analgesia in minimally invasive lung surgery?

    by Patrick Zardo

    Editorial Do we still need thoracic epidural analgesia in minimally invasive lung surgery? Patrick Zardo


  • Interdisziplinäre Behandlung der Non-Cystic-Fibrosis-Bronchiektasie – State of the Art

    by Pontus Mertsch, Hayan Merhej, Patrick Zardo

    Zusamenfassung: Bronchiektasien, die nicht durch eine Zystische Fibrose bedingt sind, sind eine ätiologisch äußerst heterogene Erkrankung. Dieser Beitrag gibt einen Überblick über die Ursachen, das diagnostische Vorgehen und die therapeutischen Optionen bei dieser nicht seltenen Lungenerkrankung.